Description
Sustained Growth Hormone Research
CJC-1295 No DAC 10mg is a research peptide studied in laboratory settings for its interaction with growth hormone signaling pathways.
CJC-1295 No DAC (Modified GRF 1-29) is a modified growth hormone-releasing hormone (GHRH) analog developed to support the body’s natural pulsatile release of growth hormone. Unlike CJC-1295 with DAC, the No DAC version does not contain a Drug Affinity Complex, resulting in a significantly shorter half-life that more closely mimics the body’s normal physiological growth hormone pulses.
Due to its pharmacokinetic profile, CJC-1295 No DAC is commonly researched alongside Ipamorelin, as the two peptides work through complementary pathways to stimulate endogenous growth hormone release.
Manufactured to rigorous quality standards and third-party tested for purity and identity, each vial reflects Riptide Wellness Labs’ commitment to premium research solutions.
Research Areas of Interest
- Growth hormone secretion and pulsatile release
- IGF-1 research
- Healthy aging and longevity studies
- Recovery and tissue regeneration research
- Sleep and recovery research
- Lean muscle development studies
- Body composition and metabolic function
Product Features
- Premium laboratory-grade quality
- Third-party tested for purity and identity
- Manufactured in the USA*
- Certificate of Analysis (COA) available
- Designed for research applications only
Whether studied independently or as part of a broader research protocol with complementary compounds such as Ipamorelin, CJC-1295 No DAC (Modified GRF 1-29) remains one of the most widely researched GHRH analogs for investigations into growth hormone physiology and healthy aging.
For Research Use Only. Not for Human Consumption.
Explore more products in our Energy and Performance collection.
For additional scientific background, review published research on CJC-1295 NO DAC in PubMed
Reviews
There are no reviews yet.